Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Dr. Victoria Veytsman Continues Partnership With Exclusive Haute Beauty Network


Dr. Veytsman started her practice from scratch with the vision of merging health and beauty and having dentistry be a different, fun experience that patients would look forward to.

Dr. Victoria Veytsman, owner of Cosmetic Dental Studios is one of the premier cosmetic dentists in New York City. Her unique set of technical skills across multiple areas of dentistry along with her compassion and commitment toward patient comfort have allowed her to earn a superlative reputation amongst her patients and colleagues. An artist at heart, Dr. Veytsman has a passion for smile transformations where art and science come together to create healthy, beautiful smiles every day.

Dr. Veytsman is the youngest graduate of New York University College of Dentistry at the age of 22. She completed a residency at St. Lukes-Roosevelt, a Columbia College of Physicians and Surgeons Hospital. She is a graduate of several cosmetic post-graduate programs including The Hornbrook Group for Advanced Clinical Education in San Diego and Dental Aesthetic Masters at the University of Nevada Las Vegas. Dr. Veytsman has trained with some of the world’s best cosmetic dentists at the Nash Institute, the Los Angeles Institute of Esthetic Dentistry, the Center for Esthetic Excellence, and completed a two-year fellowship at NYU in dental implantology.

Dr. Veytsman is also involved in a Biotechnology Enterprise program at John’s Hopkins University. She is a fellow of Academy of Dental Facial Esthetics, a member of the American Academy of Cosmetic Dentistry, The American Dental Association, the International Congress of Oral Implantologists, and the Royal Society of Medicine, UK.

Dr. Veytsman started her practice from scratch with the vision of merging health and beauty and having dentistry be a different, fun experience that patients would look forward to. Her private practice is built upon a solid foundation of experience running the gamut from general dentistry, cosmetic and restorative, to implantology and functional aesthetics. She has earned a notable reputation for compassionate care and creating beautiful smiles for adults and teens alike.

Dr. Veytsman’s niche in cosmetic dentistry has led her to create gorgeous smiles for some of the top beauties in New York, which include: The Miss Universe Organization: Miss New York USA, Miss New York Teen USA, The Miss America Organization, Miss New York, Miss New York Latina Organization; multiple New York Cheerleading teams including the Brooklyn Nets and New York Giants; and the lead sponsor of the New York Emmy’s along with celebrities, models and TV personalities. She has been a featured smile expert on WebMD, NewBeauty, Latina Magazine, Brides, Yahoo!Health, Social Life Magazine, Hamptons Magazine, NBC’s The Today Show, and more.

As a native New Yorker, Dr. Veytsman understands the importance of giving back to the community and developed the “smile for a smile” campaign. She is involved with several charities: Operation Smile, the Bowery Mission, Urban Tech, National Hemophilia Foundation, Smile Train, and B4BC.org (Boarding for Breast Cancer). Dr. Veytsman donates 50 percent of all teeth-whitening to B4BC.org in support of programs that educate young women on breast cancer.

“Being able to provide my patients with the best in dental treatment options and patient comfort gives me the greatest pleasure and I consider it my biggest privilege. I enjoy the process of getting to know every individual, taking care of them, and creating customized beautiful and healthy smiles.”

Learn more about Dr. Victoria Veytsman by visiting: https://hauteliving.com/hautebeauty/member/dr-victoria-veytsman/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Share article on social media or email:

Achieving Quality Cell and Gene Therapies Outcomes Through Multidisciplinary Collaboration, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

Timely and unrestricted support is crucial for the safe progress of CGT.

During the last five years, the number of cell and gene therapies (CGT) have exponentially increased, stimulated by their efficacy and potential for cure. However, CGT can expose the patients to significant toxicities such as cytokine release syndrome (CRS) and neurotoxicities (ICANS), requiring specialised and accurate management associated with precise data capture and analysis. Timely and unrestricted support is crucial for the safe progress of CGT. In addition, dealing with these “living therapies” represents what’s been called the most complex supply chain in the history of medicine.

This webinar will present and discuss the challenges involved in supporting CGT-related clinical trials. Attendees will gain first-hand learning from members of a multidisciplinary team that was developed at ICON for the successful support of CGT clinical trials.

The participants will learn the following during the presentation:

A – The medical landscape:

  • Principles and summary of current CGT in oncology
  • Medical monitoring in CGT clinical trials
  • The impact of COVID-19 and the associated risks in CGT clinical trials
  • Patient reported outcomes considerations

B – Operational management:

  • Operational nuances in CGT versus traditional clinical trials
  • Effectively coordinating key stakeholders
  • Potential responses to operational complexities

C – Commercialisation and logistics

  • Early phase consulting supporting regulatory and reimbursement goals
  • Logistics orchestration
  • Scaling for commercialisation

Join Anne S. Renteria, MD, Medical Director, Medical Affairs, ICON plc, Brandon Fletcher, PhD, Principal, Clinical Project Management, ICON plc and Tamie Joeckel, Business Lead, Cell and Gene Therapy Center of Excellence, ICON plc in a live webinar on Thursday, September 24, 2020 at 10am EDT (3pm BST/UK).

For more information or to register for this event, visit Achieving Quality Cell and Gene Therapies Outcomes Through Multidisciplinary Collaboration.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Seton Hall University Offers Test-Optional Admissions for Fall 2021 Applicants Amid COVID-19 Pandemic


We recognize that there are gifted, hard-working students who have been unable to take standardized tests, and we don’t want to deprive them of the ability to access a Seton Hall education,” said Alyssa McCloud, Ph.D., Senior Vice President of Enrollment Management.

Seton Hall University announced that students seeking admission for the fall 2021 semester will not be required to submit standardized test scores as part of the application process. The University will become a “test-optional” institution so that SAT and ACT scores will not be mandatory for students applying at this time.

“This is a temporary accommodation to assist students during the very difficult circumstances created by the global COVID-19 pandemic. We recognize that there are gifted, hard-working students who have been unable to take standardized tests, and we don’t want to deprive them of the ability to access a Seton Hall education,” said Alyssa McCloud, Ph.D., Senior Vice President of Enrollment Management. “Many families are struggling, and we don’t want to add any stress or anxiety during this challenging time. That is why I am so glad we could make this accommodation temporarily to support students through the application process.”

Seton Hall will take a holistic approach to reviewing all applications for admission and will review all aspects of the student’s record with a heavy emphasis on the student’s academic record in high school, specifically looking at grades, academic rigor, and class rank (if available). Students will have the option to apply to Seton Hall by submitting standardized test scores or electing not to submit these scores.

The University awards many students scholarships automatically upon admission, and students who apply test optional will receive equal consideration for these awards. Also, students can apply test optional to gain admissions to the honors and leadership programs. Applications will receive a holistic review based on the student’s academic record as well as supplemental application materials required for these programs.

To learn more about the test-optional policy, please visit http://www.shu.edu/testoptional. Families who would like further guidance are invited to speak with the admissions staff by calling 973-313-6145 or 973-313-6146 or e-mailing thehall@shu.edu. In addition, students are invited to participate in Seton Hall’s Virtual Open House being held online on Tuesday, August 18, 2020 from 12 noon to 3:45 p.m. EST, where they can attend academic presentations, connect with admissions and financial aid officers, students faculty and deans, and learn about next steps.

Virtual Open House Registration Dates will be offered:


  • Sunday, September 27 at 11 a.m. ET
  • Sunday, October 18 at 11 a.m. ET 
  • Sunday, November 1 at 11 a.m. ET 
  • Sunday, November 22 at 11 a.m. ET

One of the country’s leading Catholic universities, Seton Hall has been showing the world what great minds can do since 1856. In the past decade, Seton Hall students and alumni have received more than 30 Fulbright Scholarships as well as other prestigious academic honors, including Boren Awards, Pickering Fellowships, Udall Scholarships and a Rhodes Scholarship.

“Students from throughout New Jersey and around the country are attracted to Seton Hall’s outstanding academic reputation, our Catholic values and our warm and nurturing community where they can thrive as exemplary servant leaders and global citizens. We are a university continually on the rise, and we encourage students to learn more about our tradition of excellence,” said McCloud.

An online version of this release can be found here.

ABOUT SETON HALL UNIVERSITY

One of the country’s leading Catholic universities, Seton Hall has been showing the world what great minds can do since 1856. Home to nearly 10,000 undergraduate and graduate students and offering more than 90 rigorous academic programs, Seton Hall’s academic excellence has been singled out for distinction by The Princeton Review, U.S. News & World Report and Bloomberg Businessweek.

Seton Hall embraces students of all religions and prepares them to be exemplary servant leaders and global citizens. In recent years, the University has achieved extraordinary success. Since 2009, it has seen record-breaking undergraduate enrollment growth and an impressive 110-point increase in the average SAT scores of incoming freshmen. In the past decade, Seton Hall students and alumni have received more than 30 Fulbright Scholarships as well as other prestigious academic honors, including Boren Awards, Pickering Fellowships, Udall Scholarships and a Rhodes Scholarship. The University is also proud to be among the most diverse national Catholic universities in the country.

In recent years, the University has invested more than $165 million in new campus buildings and renovations. The University’s beautiful main campus in suburban South Orange, N.J. is only 14 miles from New York City — offering students a wealth of employment, internship, cultural and entertainment opportunities. Seton Hall’s nationally recognized School of Law is located prominently in downtown Newark. The University’s Interprofessional Health Sciences (IHS) campus in Clifton and Nutley, N.J. opened in the summer of 2018. The IHS campus houses Seton Hall’s College of Nursing, its School of Health and Medical Sciences as well as Hackensack Meridian Health’s Hackensack Meridian School of Medicine.

For more information, visit http://www.shu.edu.

Share article on social media or email:

Aesthetics Biomedical® Inc. Announces Key Scientific Findings Scientific Findings For Vivace® Radiofrequency Microneedling Device


Vivace Microneedling

Vivace Microneedling

A clearer objective understanding of the electrocoagulation and thermal effects with different amplitudes and needles is important to provide Radiofrequency Microneedling practitioners with a more precise treatment to achieve better aesthetic outcomes including less pain

Aesthetics Biomedical® Inc. (ABM), a regenerative aesthetics medical device and topical skincare company announces new scientific findings for its radiofrequency microneedling (RFMN) device, Vivace®. There has been an increasing demand for minimally-invasive procedures to address aging facial skin and other skin conditions. The energy-based radiofrequency device market continues to grow as these aesthetic patients look for effective anti-aging treatments with little associated downtime. The Vivace® is the leader in RF devices, allowing safe and efficacious aesthetic treatments by plastic surgeons, cosmetic dermatologists, and other aesthetic professionals. Clinical studies demonstrate cosmetic efficacy using RFMN devices; however, there still remains a paucity of information to explain the RF electrocoagulation mechanism on various layers of the skin, and the impact of using insulated vs. non-insulated needles. Practitioners want a more definitive understanding of how the thermal effects which occur with these devices and associated needles actually perform and can change aesthetic outcomes.

The study by Aesthetics Biomedical® Inc., a first of its kind, looked at the role of 1MHz and 2MHz amplitudes using both insulated and non-insulated needles. The 1MHz insulated needles produced an ovular shaped area of electrocoagulation and a larger surface area of controlled thermal injury as opposed to the 2MHz insulated needles, which produced a narrow columnar area of thermal injury with a smaller surface area of involvement. The histological results in the study provide practitioners with a more precise understanding of the thermal coagulation and heat dissipation effect associated with the use of different frequencies as well as the use of insulated and non-insulated needles. In summary, Vivace® treatments lead to neocollagenesis and tissue repair, including facial rejuvenation. The results of the study were published in an article titled, “An Evaluation of Electrocoagulation and Thermal Diffusion Following Radiofrequency Microneedling Using an In-Vivo Porcine Skin Model” (in press; Journal Cosmetic Dermatology)

Shaun Wootten, Director of Research & Development at Aesthetics Biomedical®, and lead author stated, “A clearer objective understanding of the electrocoagulation and thermal effects with different amplitudes and needles (insulated vs. non-insulated) is important to provide practitioners with a more precise treatment to achieve a better aesthetic outcome, including less pain and greater comfort for the patient. Additional studies are needed to further delineate the effects of RF energy on targeted and nearby tissues.”

Lawrence Rheins, Ph.D., Aesthetics Biomedical’s Chief Scientific Officer and co-author of the publication, stated, “There is a significant amount of research out there that demonstrates the safety and efficacy of radiofrequency microneedling devices. There remain gaps in our knowledge of the critical impact to the skin. The objective, histological data provides the practitioner with additional specificity regarding the accurate placement of the needles and expected efficacious aesthetic outcomes for the patient. The aesthetic industry moves quickly, and one can expect even more precise devices in the future as both the physician and patient look for more cost-effective, superior treatment for skin improvement.”

Aesthetics Biomedical® continues to focus on the company’s scientific research on the development of superior aesthetic medical devices for practitioners and patients worldwide.

ABOUT AESTHETICS BIOMEDICAL®: Aesthetics Biomedical®, Inc., headquartered in Phoenix, Ariz., is committed to the development and distribution of novel aesthetic devices, products, and services in the global market. Aesthetics Biomedical’s innovation center is a leader in breakthrough technologies and combination therapies for its clients, physician network and the aesthetic arena, creating novel patient treatment experiences that benefit from ongoing research, approved clinical indications for use, as well as a personalized approach designed for consumer benefit. For more information, please visit https://www.aestheticsbiomedical.com/.

Share article on social media or email:

Oncology Product Launch – The Toolkit for Success, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

On the back end, product life cycles are shortening, with the number of years until competitive follow-on launches compressed dramatically. This sets the stage for a demanding oncology product launch readiness effort for commercial teams.

Product launch is a critical stage of the product lifecycle and often sets the brand trajectory for years to come. Oncology product launches can present particular challenges specific to commercializing in the oncology space. With the high unmet need in oncology, new assets are aiming at commercialization for many oncologic indications at a rapid pace. Given the high level of breakthrough designations among oncology assets, nearly half of the products are approved in phase II, with limited data and rapid launch timeframes. On the back end, product life cycles are shortening, with the number of years until competitive follow-on launches compressed dramatically. This sets the stage for a demanding oncology product launch readiness effort for commercial teams.

Oncology product launch readiness has unique critical success factors. Extensive understanding of clinical profiles and significant market shaping efforts become imperative within the journey of how to best arm the field teams for KOL engagement. Access and affordability requires navigating complex patient journeys and understanding the implications of buy and bill products.

This webinar will review launch readiness planning elements and timelines, including how to address the accelerated review timelines and launch scenarios oncology product launch may face. Critical areas of focus for successful oncology product launch success will be highlighted. Collaboration across partnerships and co-promotion, which is quite common in this area, will be discussed.

Join Vivienne Ho, PhD, Manager, Herspiegel Consulting, Swathi Rangan, MBA, Senior Manager, Herspiegel Consulting and Anne Brooks Vice President of Marketing at Iovance Biotherapeutics, Inc. in a live webinar on Wednesday, September 23, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Oncology Product Launch – The Toolkit for Success.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Pink Pint Night Benefit Focuses on Saving Lives Through Screening


One hundred percent of the money raised at Pink Pint Night directly impacts local uninsured women, providing free screening mammograms and saving lives through early detection.

Charlotte Radiology today announces their 9th Annual Pink Pint Night on September 24th benefiting Levine Cancer Institute: Project PINK. This year’s Pink Pint Night (PPN) Virtual Edition will raise funds to provide over 1,000 low-income, uninsured women in the greater Charlotte community with access to screening mammograms and related breast services. In partnership with NoDa Brewing Company, Pink Pint Night Virtual Edition will include community education about the impact of LCI: Project Pink as well as a guided NoDa Brewing Company craft beer ‘flight tasting’, a feature band, and online auction.

“Each year, Pink Pint Night is a highly anticipated event that brings our Charlotte community together for a great cause. While we’ll miss seeing our friends, neighbors, and supporters in person this year, we remain committed to our fight against breast cancer and providing essential screening services to Charlotte communities in need,” said Charlotte Radiology Chief Executive Officer Lindsay Muns. “One hundred percent of the money raised at Pink Pint Night directly impacts local uninsured women, providing free screening mammograms and saving lives through early detection.”

Project Pink Addresses Health Disparities in Our Community

Breast cancer does not stop for pandemics and the need for funding this year is more important than ever, as many state and local resources for essential health screening programs have been reprioritized to help with the COVID-19 response. Project Pink serves the same at-risk populations impacted by coronavirus at a time of critical need.

“We know that many people have concerns about visiting healthcare providers during the COVID-19 pandemic. But it is essential that women make appointments for vital health screenings because early detection saves lives,” said Dr. Amy Sobel, Section Head for Charlotte Radiology’s Breast Services. “Women served by LCI: Project Pink will experience the same high quality, safe, and caring environments for their breast services whether seen in one of our breast centers or during a mobile screening event. We encourage all women to seek out screening mammography because it could save

their life.”

Event Details

Pink Pint Night: Virtual Edition will be broadcast on September 24th starting at 6pm ET. It can be viewed on the Charlotte Radiology’s YouTube page: https://www.youtube.com/user/CharlotteRadiology and the link will also be available on their Facebook page (https://www.facebook.com/CharlotteRadiology/). Visit http://www.charlotteradiology.com/pinkpintnight/ for event updates and to learn more about ways you can participate. Those who can’t attend the event but wish to make a donation can visit Atrium Health Foundation’s Pink Pint Night fundraising page to donate directly to Project PINK.

#FightwithaFlight: Gose Pink or Go Home!

Hosted by media journalist, social creator, and kindness advocate, Kristen Hampton, the signature event at PPN will feature NoDa Brewing Company’s Head Brewer, Chad Henderson, hosting a digital flight tasting including our ninth annual distinctive Pink Pint Night brew called, “Gose PINK or Go Home!”

To participate, supporters can pre-order a PPN Host kit (flight tasting for two, including t-shirts) online via Instabuy at http://www.qtego.net/qlink/pinkpintnight2020 before midnight Sunday, September 15th. PPN Host kits are then available for pick up at NoDa Brewing during a “Brew-Thru” on September 19th and 20th between 3pm-5pm or September 21st thru September 23rd between 5pm-7pm. In lieu of pre-ordering, a limited supply of PPN Host kits will be available at the NoDa Brewing taproom located at 2921 N. Tryon Street, Charlotte NC 28206.

PPN also includes a live auction (open now), also available at http://www.qtego.net/qlink/pinkpintnight2020, and Charlotte Radiology encourages tax deductible donations and “crowdfunding” by teams, which can be coordinated via Atrium Health Foundation’s dedicated website for Pink Pint Night and LCI: Project Pink: http://www.atriumhealthfoundation.org/pinkpintnight.

About Breast Cancer:


  • 1 in 8 women in the US will be diagnosed with breast cancer. 1 in 6 diagnoses will occur in women age 40-49.
  • Breast health experts recommend screening mammography every 12 months beginning at age 40.
  • 75% of women diagnosed with breast cancer DO NOT have a family history.
  • Early detection is key. Annual screening mammograms have reduced breast cancer deaths by 40%.
  • Most insurance plans cover annual screening mammograms 100%.

Visit http://www.charlotteradiology.com to schedule a mammogram through our new online scheduling tool or call (704) 367-2232.

About Charlotte Radiology Breast Centers Charlotte Radiology is one of the largest radiology groups in the country and has served Mecklenburg and surrounding counties in NC and SC since 1967. Charlotte Radiology owns and operates 15 breast center locations and a mobile breast unit and serves more than 100,000 women each year. All breast centers are accredited by the American College of Radiology, certified by the FDA and recognized as a Breast Imaging Center of Excellence. For more information: http://www.charlotteradiology.com.

About NoDa Brewing Company Opening its tap room doors in 2011, NoDa became one of Charlotte’s first craft breweries. Three short years later, Hop Drop ‘N Roll — their most popular IPA — took home the World Beer Cup Gold Award in the competition’s largest category. This recognition propelled the brewery onto a national stage, and attributed to the quick expansion from a 15-barrel brewhouse in the NoDa neighborhood to a 60 barrel brewhouse in nearby North End. Today, NoDa Brewing Company continues to brew award-winning beers, stand as a pillar of creativity and connection in the community, and add to the state’s thriving craft beer economy. Connect with NoDa Brewing Company at http://www.nodabrewing.com, or on Instagram, Facebook and Twitter @nodabrewing.

Share article on social media or email:

More U.S. Women Are Using Facial Skincare Products Today, Reports The NPD Group


More women in the U.S. are using facial skincare products today compared to one year ago, according to new findings from The NPD Group’s 2020 Women’s Facial Skincare Consumer Report. In addition, lifestyle changes including the effects of COVID-19 have in many ways altered their skincare routines in a positive way.

Overall, close to 40% of facial skincare users report using their products more often today. Usage of basic care products such as cleansers and moisturizers, and treatments including exfoliators/scrubs and masks saw the most significant increases since last year.

When asked specifically about the pandemic, 22% of women have changed their skincare routine because of COVID-19. Most are washing or moisturizing their face more often than pre-pandemic; one-third have expanded their routine to include more products; and the majority of those using more products intend to stick with their new routine when things normalize.

“Skincare has been one of the most resilient beauty categories this year. It has seen softer sales declines year-to-date compared to the overall beauty industry and gained market share, generating the highest sales volume of all the categories,” said Larissa Jensen, NPD’s beauty industry advisor. “Using an average of five products daily, consumers are committed to their baseline facial skincare routine, which includes a combination of basic care and targeted treatments. The effects of COVID-19, including spending more time at home, have brought a greater focus on self-care, and skincare has reaped the benefits.”

About The NPD Group, Inc.

NPD offers data, industry expertise, and prescriptive analytics to help our clients grow their businesses in a changing world. Over 2,000 companies worldwide rely on us to help them measure, predict, and improve performance across all channels, including brick-and-mortar and e-commerce. We have offices in 27 cities worldwide, with operations spanning the Americas, Europe, and APAC. Practice areas include apparel, appliances, automotive, beauty, books, B2B technology, consumer technology, e-commerce, fashion accessories, food consumption, foodservice, footwear, home, juvenile products, media entertainment, mobile, office supplies, retail, sports, toys, video games, and watches. For more information, visit npd.com. Follow us on Twitter: @npdbeauty.

Share article on social media or email:

ReachMD Nominated for 2 Awards by Medical Marketing & Media 2020


News Image

Every project we undertake is executed with a passion to improve the quality of healthcare.

ReachMD is proud to announce it has been nominated again for ‘Best Healthcare Media Brand’ by Medical Marketing & Media (MM&M), leaders in healthcare marketing and media recognition. MM&M also nominated ReachMD for ‘Best Digital Initiative for Non-consumers’, marking the 11th award nomination for ReachMD by MM&M.

“Every project we undertake is executed with a passion to improve the quality of healthcare,” said Frank Russomano, President & CEO of ReachMD. “Users and supporters tell us they appreciate what we do, but industry recognition makes our team members especially proud.”

ReachMD’s award submission for the category of ‘Healthcare Professional Media Brand’ focuses on advanced practices in professional education—including measuring time in media, personalizing the user experience, delivering top-quality Series, and driving deeper engagements in educational programing.

ReachMD’s submission for the category of ‘Best Digital Initiative for Non-consumers’ focuses on the Eye Health Academy: An NEI Blindness Prevention Initiative, built in partnership with Prova Education and the National Eye Institute of the NIH. More than 30 million Americans are at risk for vision loss and blindness as a complication of diabetes, and this initiative aims to educate primary care clinicians, endocrinologists, optometrists, ophthalmologists, and retina specialists to be assertive in patient referrals or treatment of diabetic retinopathy and diabetic macular edema.

MM&M winners will be announced on October 8, 2020.

ABOUT REACHMD

ReachMD revolutionizes healthcare education for medical professionals by delivering a personalized experience for each user – on desktop, mobile, radio, and email. No other site puts users in control quite like ReachMD. Watch it, listen to it, read it: Every program is offered in multiple formats to match user needs. ReachMD teams with agencies, pharmaceutical companies, device manufacturers, CME enterprises, and others to execute education strategies through live broadcasts, on-demand programming, and multiple 24/7 radio streams. ReachMD programming is accessible through ReachMD, Amazon Alexa, Spotify, iHeartRadio, TuneIn, iTunes, Stitcher, Google Play, and PlayerFM. ReachMD also offers a multi-channel advertising platform. With more than 10,000 medical podcasts at users’ fingertips, ReachMD leads the way in healthcare professional education.

Share article on social media or email:

Red Nucleus Acquires Life Science Training Institute


Red Nucleus logo

Red Nucleus

“With LSTI, we can offer our R&D clients ‘off-the-shelf’ training solutions…including but not limited to robust GLP, GMP, and GCP training.” Ian Kelly, CEO, Red Nucleus

Red Nucleus, a premier provider of learning, performance, and process solutions for the life sciences industry, announced that it has acquired Life Science Training Institute (“LSTI”), a leading provider of live instruction, on-demand, and custom compliance training courses for the pharmaceutical, medical device, and biotech industries.

LSTI, with an online subscription library of over 200 courses and unique custom training solutions, will become part of Red Nucleus’s rapidly growing R&D business. Red Nucleus’s R&D business delivers unrivaled capabilities in a broad array of services, including but not limited to compliance with Global and Regional Health Authority requirements throughout the drug lifecycle.

With the acquisition, Red Nucleus further extends the capabilities of its learning platform from R&D through their Commercial business, which designs and develops training content that includes e-learning modules, mobile apps, virtual training, workshops, games, and printed materials primarily focused on the commercialization of pharmaceuticals.

Dalia El-Sherif, PhD, Red Nucleus R&D Strategy and Change Partner, commented, “Red Nucleus has deep in-house experience with tailored content and training programs for both the R&D and Commercial sides of the business and, now with LSTI, we can offer our R&D clients ‘off-the-shelf’ training solutions across a variety of topics delivered through role-based curricula, including but not limited to robust GLP, GMP, and GCP training.”

Bill Beyer, LSTI Founder, adds “For over seven years, LSTI has been a trusted training provider for R&D and manufacturing functions within the life sciences. By teaming with Red Nucleus and their award-winning team and products, we will have the opportunity to better serve our clients. We are very excited to join an industry-leading organization.”

“We are very pleased to add LSTI to the Red Nucleus family,” said Red Nucleus CEO Ian Kelly. “There is strong overlap with LSTI’s content and training solutions and our heritage as a content and training business. Red Nucleus’s goal is to be the trusted life sciences partner across our clients’ product lifecycle, and we are thrilled to now offer our R&D clients additional learning solutions focused on increasing compliance with Global and Regional Health Authority requirements.”

The transaction closed in September 2020.

For more information, please contact

Jeff Warwick

jwarwick@rednucleus.com

302.437.4452

About Red Nucleus

Red Nucleus is the premier provider of strategic learning, performance, and process solutions exclusively for the life sciences industry. Our global solutions engage and inspire teams across the commercial and R&D spaces and are designed to boost understanding, efficacy, and compliance.

Squarely focused on the life sciences industry for close to 30 years, Red Nucleus takes pride in our long-term relationships with industry leaders, as well as our strategic partnerships with innovative startups. We are focused on developing thoughtful, high-quality solutions that are in accordance with each client’s unique culture and process.

Our clients trust us to build impactful, award-winning programs that deliver actionable insights and measurable results.

Red Nucleus is headquartered in Yardley, PA. The Red Nucleus R&D office is located in Malvern, PA. The company also has offices in Boston, MA, the United Kingdom, India, and Japan.

Visit http://www.rednucleus.com to learn more.

Share article on social media or email: